Mark Gelfand
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$5.2MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $5.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 31, 2026 | NIH | SBIR Phase II ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea | $1.0M | Coridea, LLC |
| Sep 11, 2025 | NIH | SBIR Phase II ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea | $982K | Coridea, LLC |
| Dec 10, 2021 | NIH | SBIR Phase II Endobronchial Supervalve for the Treatment of Emphysema | $988K | Coridea, LLC |
| Dec 1, 2020 | NIH | SBIR Phase II Endobronchial Supervalve for the Treatment of Emphysema | $1.9M | Coridea, LLC |
| Apr 10, 2020 | NIH | SBIR Phase II Endobronchial Supervalve for the Treatment of Emphysema | $246K | Coridea, LLC |
1 patents as inventor
- US Coridea, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#271
Awards as PI#470
Patents#505
Companies
- Coridea, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.